Akebia Therapeutics Inc
AKBA1.390USD
+0.010+0.72%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
368.66M시가총액
손실P/E TTM
자세한 내용은 Akebia Therapeutics Inc 회사
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with two commercial products for patients impacted by kidney disease. The Company is focused on developing and commercializing therapeutics. Its two preclinical development candidates are AKB-9090 and AKB-10108. The Company’s portfolio and hypoxia-inducible factor (HIF)-based commercialized products include Auryxia (ferric citrate) and Vafseo. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the United States for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Vafseo, an oral HIF prolyl hydroxylase (HIF-PH), inhibitor. It utilizes third parties for the commercial distribution of Auryxia, including wholesale distributors and certain specialty pharmacy providers.
Akebia Therapeutics Inc 정보
종목 코드 AKBA
회사 이름Akebia Therapeutics Inc
상장일Mar 20, 2014
CEOButler (John P)
직원 수181
유형Ordinary Share
회계 연도 종료Mar 20
주소245 First Street
도시CAMBRIDGE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02142
전화16178712098
웹사이트https://akebia.com/
종목 코드 AKBA
상장일Mar 20, 2014
CEOButler (John P)
Akebia Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.25M
-166055.00%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
170.50K
+35700.00%
Mr. Nicholas (Nik) Grund
Mr. Nicholas (Nik) Grund
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
164.65K
-84829.00%
Mr. Michael W. Rogers
Mr. Michael W. Rogers
Independent Director
Independent Director
131.73K
+35700.00%
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
130.93K
+35700.00%
Mr. Erik Ostrowski
Mr. Erik Ostrowski
Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer
Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer
127.73K
-34951.00%
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
122.83K
+35700.00%
Dr. Myles Wolf, M.D.
Dr. Myles Wolf, M.D.
Independent Director
Independent Director
103.38K
+35700.00%
Dr. Steven K. Burke, M.D.
Dr. Steven K. Burke, M.D.
Senior Vice President - Research and Development, Chief Medical Officer
Senior Vice President - Research and Development, Chief Medical Officer
--
--
Ms. Leanne M. Zumwalt
Ms. Leanne M. Zumwalt
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.25M
-166055.00%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
170.50K
+35700.00%
Mr. Nicholas (Nik) Grund
Mr. Nicholas (Nik) Grund
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
164.65K
-84829.00%
Mr. Michael W. Rogers
Mr. Michael W. Rogers
Independent Director
Independent Director
131.73K
+35700.00%
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
130.93K
+35700.00%
Mr. Erik Ostrowski
Mr. Erik Ostrowski
Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer
Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer
127.73K
-34951.00%
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, Feb 5
마지막 업데이트: Thu, Feb 5
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
6.30%
The Vanguard Group, Inc.
6.01%
State Street Investment Management (US)
4.46%
Geode Capital Management, L.L.C.
2.33%
Alerce Investment Management, L.P.
2.17%
기타
78.73%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
6.30%
The Vanguard Group, Inc.
6.01%
State Street Investment Management (US)
4.46%
Geode Capital Management, L.L.C.
2.33%
Alerce Investment Management, L.P.
2.17%
기타
78.73%
주주 유형
주주
비율
Investment Advisor
20.52%
Investment Advisor/Hedge Fund
15.28%
Hedge Fund
7.09%
Individual Investor
4.16%
Research Firm
3.64%
Private Equity
2.18%
Pension Fund
0.35%
Bank and Trust
0.35%
Insurance Company
0.03%
기타
46.39%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
322
132.23M
46.40%
+1.48M
2025Q3
319
130.76M
46.38%
+15.12M
2025Q2
289
114.82M
39.60%
+12.72M
2025Q1
262
102.34M
28.68%
+27.30M
2024Q4
243
68.25M
29.95%
+8.53M
2024Q3
241
59.59M
29.67%
+2.86M
2024Q2
231
56.74M
30.94%
-537.20K
2024Q1
275
57.32M
33.03%
-11.84M
2023Q4
274
54.98M
40.78%
+1.55M
2023Q3
287
53.47M
42.97%
+287.09K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
16.72M
6.3%
+141.44K
+0.85%
Sep 30, 2025
The Vanguard Group, Inc.
15.48M
5.83%
+868.43K
+5.94%
Sep 30, 2025
State Street Investment Management (US)
11.84M
4.46%
+3.85M
+48.11%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.18M
2.33%
+110.49K
+1.82%
Sep 30, 2025
Alerce Investment Management, L.P.
5.75M
2.17%
--
--
Dec 31, 2024
Satter Muneer A
5.75M
2.17%
+5.75M
--
Dec 31, 2024
Renaissance Technologies LLC
3.95M
1.49%
-241.70K
-5.76%
Sep 30, 2025
Morgan Stanley & Co. LLC
3.34M
1.26%
-1.01M
-23.21%
Sep 30, 2025
Qube Research & Technologies Ltd
3.21M
1.21%
+1.49M
+87.00%
Sep 30, 2025
Citadel Advisors LLC
3.19M
1.2%
+868.54K
+37.48%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco Biotechnology & Genome ETF
1.9%
Invesco NASDAQ Future Gen 200 ETF
0.38%
State Street SPDR S&P Biotech ETF
0.26%
ALPS Medical Breakthroughs ETF
0.24%
First Trust Small Cap Growth AlphaDEX Fund
0.22%
Federated Hermes MDT Small Cap Core ETF
0.18%
Direxion Daily S&P Biotech Bull 3X Shares
0.16%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Fidelity Enhanced Small Cap ETF
0.08%
더 보기
Invesco Biotechnology & Genome ETF
비율1.9%
Invesco NASDAQ Future Gen 200 ETF
비율0.38%
State Street SPDR S&P Biotech ETF
비율0.26%
ALPS Medical Breakthroughs ETF
비율0.24%
First Trust Small Cap Growth AlphaDEX Fund
비율0.22%
Federated Hermes MDT Small Cap Core ETF
비율0.18%
Direxion Daily S&P Biotech Bull 3X Shares
비율0.16%
iShares Micro-Cap ETF
비율0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.08%
Fidelity Enhanced Small Cap ETF
비율0.08%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
